Last 0.55 MYR
Change Today -0.005 / -0.90%
Volume 3.2M
TMCL On Other Exchanges
Kuala Lumpur
As of 3:58 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

tmc life sciences bhd (TMCL) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/26/14 - 0.67
52 Week Low
01/24/14 - 0.37
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TMC LIFE SCIENCES BHD (TMCL)

Related News

No related news articles were found.

tmc life sciences bhd (TMCL) Related Businessweek News

No Related Businessweek News Found

tmc life sciences bhd (TMCL) Details

TMC Life Sciences Berhad, an investment holding company, primarily operates a multi-disciplinary tertiary care center and fertility center in Malaysia. The company’s tertiary care center provides healthcare services in various medical/surgical specialties and subspecialties, including anaesthesiology, obstetrics and gynaecology, ophthalmology, cardiology, dermatology, endocrinology, gastroenterology, fertility, hepatology, internal medicine, nephrology, paediatrics, psychiatry, radiology and interventional radiology, respiratory medicine, and urology, as well as breast and endocrine, cancer, cardiothoracic, colorectal, ENT, head and neck laser, general and minimally invasive, hepatobiliary, neuro, hand and micro, bariatric, oral and maxillofacial, orthopaedic, plastic and reconstructive, vascular and endovascular, and upper gastrointestinal surgeries. Its fertility center provides a range of fertility treatments for couples. The company also operates a women’s clinic; provides consultancy, laboratory, and embryology services; and offers gynaecological and fertility problem management services. In addition, it is involved in developing, marketing, and managing healthcare programs; and marketing and promoting healthcare products; and research and development, and property investment activities. TMC Life Sciences Berhad was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.

Founded in 1994

tmc life sciences bhd (TMCL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tmc life sciences bhd (TMCL) Key Developments

TMC Life Sciences Berhad Reports Unaudited Consolidated Earnings Results for the Quarter Ended August 31, 2014

TMC Life Sciences Berhad reported unaudited consolidated earnings results for the quarter ended August 31, 2014. For the quarter, the company’s revenue was MYR 23,172,000 against MYR 18,807,000 a year ago. Profit from operations was MYR 2,389,000 against MYR 1,502,000 a year ago. Interest income was MYR 237,000 against MYR 178,000 a year ago. Profit before taxation was MYR 643,000 against loss before taxation of MYR 316,000 a year ago. Profit attributable to owners of the parent was MYR 728,000 against loss attributable to owners of the parent of MYR 368,000 a year ago. Diluted earnings per share from continuing operations MYR 0.06. Net cash flows from operating activities was MYR 2,237,000 against MYR 1,897,000 a year ago. Acquisition of property plant and equipment was MYR 3,294,000 against MYR 992,000 a year ago. Revenue rose by 23% to MYR 23.2 million compared to the previous corresponding quarter was mainly attributable to higher patient load catered for by increased bed capacity and additional consultants recruited. Profitability improved due to higher revenue recorded.

TMC Life Sciences Berhad Proposes Final Single Tier Dividend for the Financial Year Ended May 31, 2014, Payable on November 12, 2014

TMC Life Sciences Berhad proposed final single tier dividend of 0.3 sen per ordinary share in respect of the financial year ended May 31, 2014. The dividend will be paid on November 12, 2014 and the ex-date is October 24, 2014. Entitlement date is October 28, 2014.

TMC Life Sciences Berhad, Annual General Meeting, Oct 24, 2014

TMC Life Sciences Berhad, Annual General Meeting, Oct 24, 2014., at 16:30 Singapore Standard Time. Location: Auditorium, Tropicana Medical Centre, No. 11. Agenda: To receive the Audited Financial Statements for the financial year ended 31 May 2014 and the Reports of Directors and Auditors thereon; to approve a final single tier dividend of 0.3 sen per ordinary share in respect of the financial year ended 31 May 2014; to re-elect Dr. Chan Boon Kheng who is retiring in accordance with Article 96(1) of the Company's Articles of Association; to re-appoint Auditors of the Company and authorise the Directors to determine their remuneration; and to consider authority to issue shares.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMCL:MK 0.55 MYR -0.005

TMCL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMCL.
View Industry Companies

Industry Analysis


Industry Average

Valuation TMCL Industry Range
Price/Earnings 85.7x
Price/Sales 4.4x
Price/Book 2.9x
Price/Cash Flow 78.5x
TEV/Sales 6.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TMC LIFE SCIENCES BHD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at